Prostate Cancer Clinical Trials in Florida

Showing 81-100 of 109 trials

Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery

NCT02080689

The influence of Decipher test on urologist and patient treatment plan choices immediately post RP and at the time of PSA rise or BCR

Prostate Cancer

GenomeDx Biosciences Corp286 participantsStarted May 2014

Anchorage, Alaska, United States • Los Angeles, California, United States • Aurora, Colorado, United States +16 more locations

COMPLETEDPHASE225 miles

Ixabepilone in Treating Patients With Metastatic Prostate Cancer

NCT00087139

Drugs used in chemotherapy, such as ixabepilone, work in different ways to stop tumor cells from dividing so they stop growing or die. This phase II trial is studying how well ixabepilone works in treating patients with metastatic prostate cancer that has not responded to previous hormone therapy.

Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer

National Cancer Institute (NCI)124 participantsStarted Sep 2004

Aurora, Colorado, United States • Boulder, Colorado, United States • Colorado Springs, Colorado, United States +159 more locations

Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery

Ixabepilone in Treating Patients With Metastatic Prostate Cancer

Prostate Cancer Trials in Other Cities

Multi-site Decision Impact Study for Decipher

Analyses of Human Samples Collected in Clinical Trials

Prostate Cancer Intervention Versus Observation Trial (PIVOT)

PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment

Once-daily Oral Seviteronel in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone.

Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer

Pilot Study on Focal Prostate Radio-Frequency Ablation

3-AP in Treating Patients With Advanced Prostate Cancer

Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer

A Phase 1/1b Study of MEDI3726 in Adults Subjects With Metastatic Castration Resistant Prostate Cancer

Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer

Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer

Clinical Study of the Sonablate® 500 to Treat Localized (T1c/T2a) Prostate Cancer

A Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial)

Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer

Other Conditions in Florida